CLINICIAN REVIEWEDEVIDENCE-BASEDCondition entity

COVID-19

COVID-19 is an infectious disease caused by SARS-CoV-2. It ranges from mild respiratory illness to severe multi-organ disease, can recur through reinfection, and can be followed by post-COVID condition (long COVID).

At a glance

Quick facts

Cause
SARS-CoV-2
Transmission
Mainly respiratory particles
Typical current symptoms
Fever · chills · sore throat
Severe-risk groups
Older adults · underlying conditions · immunocompromise
Vaccination
Reduces severe disease and death
Long-term effects
About 6% develop post-COVID condition
Medically reviewed

Dr. Fitsum Admasu Tinsae

General Medicine · Public Health · Digital Health

Reviewed for clinical accuracy, clarity and practical public-health context.

Terminology

COVID-19 is also referred to as Coronavirus disease 2019, COVID, SARS-CoV-2 disease.

Clinical profile

COVID-19 at a glance

Reference profile
CauseSARS-CoV-2A coronavirus first identified in 2019
CourseUsually self-limitedSeverity ranges widely
TransmissionRespiratory particlesClose contact and shared indoor air matter
PreventionLayered measuresVaccination, staying home when sick, ventilation, masks in higher-risk situations
TreatmentRisk-basedEarly antivirals for eligible higher-risk patients

Overview

COVID-19 is caused by SARS-CoV-2, a respiratory virus that continues to circulate globally. Most people recover without specific treatment, but severe disease still occurs and some people develop post-COVID condition (long COVID).

This entity page provides the clinical overview. The deeper reference pages below separate major search intents and preserve the history of how evidence changed during the pandemic.

Symptoms and signs

Symptoms range from mild to severe and can overlap with influenza and other respiratory infections.

1 expert note

When assessing suspected COVID-19 I ask about the full symptom pattern, including fever, cough, fatigue, sore throat, headache, muscle aches, breathing difficulty, changes in taste or smell and gastrointestinal symptoms.

SYMPTOM MATRIX

How covid-19 may present

A practical grouping for reference; not every person has every feature.

Scan by urgency
Common
  • Fever or chills
  • Sore throat
  • Cough
  • Congestion or runny nose
  • Fatigue
  • Headache
  • Muscle or body aches
Can also occur
  • Shortness of breath
  • Nausea or vomiting
  • Diarrhoea
  • New loss of taste or smell
  • Few or no noticeable symptoms
Urgent assessment
  • Trouble breathing
  • Persistent chest pain or pressure
  • New confusion
  • Inability to wake or stay awake
  • Pale, gray or blue skin/lips/nail beds depending on skin tone

Emergency warning signs require urgent medical assessment.

Diagnosis and assessment

Symptoms and exposure history establish pre-test probability but cannot confirm COVID-19.

1 expert note

Symptoms and exposure history help estimate the likelihood of COVID-19 but do not confirm infection. Viral testing is used for confirmation when testing is indicated and available.

Diagnostic pathway

How covid-19 is assessed

Testing and clinical context are interpreted together.

Assessment
1Symptoms / exposureSymptoms and exposure history establish pre-test probability but cannot confirm COVID-19.
2Choose a viral testNAAT/PCR or antigen testing can detect current infection.
3Interpret timingA negative antigen test may need repeating; recent infection can complicate NAAT interpretation.
4Assess severe-disease riskAge, underlying conditions, pregnancy and immune status can change treatment urgency.
5Reassess if symptoms worsenSevere symptoms or emergency warning signs need prompt medical care.

Treatment and care

Most people with mild illness recover without prescription antiviral therapy, but they should monitor symptoms and reduce the chance of spreading infection.

1 expert note

Treatment depends on severity and risk. Some patients need only supportive care, while selected higher-risk or severe cases may need antivirals or other targeted therapies.

Treatment & care hub

Managing covid-19

Care depends on severity, risk factors and individual circumstances.

Care pathways
Mild illnessSupportive care

Rest, fluids and symptom relief

Most people with mild illness recover without prescription antiviral therapy, but they should monitor symptoms and reduce the chance of spreading infection.

Higher riskTime-sensitive

Early antiviral assessment

Eligible patients at higher risk of severe disease may benefit from antivirals started within the first several days of symptoms.

Severe diseaseClinical care

Hospital-based management

Severe COVID-19 can require oxygen, antivirals, anti-inflammatory treatment, thrombosis prevention or organ support depending on the clinical situation.

After infectionFollow-up

Persistent symptoms

Symptoms lasting or developing after acute infection may require assessment for post-COVID condition and individualized rehabilitation or symptom management.

WHO global context

COVID-19 remains a global health issue

Cumulative reported case and death counts describe the historical scale of the pandemic; current national reporting is incomplete and not directly comparable.

WHO COVID-19 fact sheet ↗
Reported cases since Dec 2019Nearly 780MWHO fact sheet · 27 Nov 2025
Reported deaths>7.1M
Current statusOngoing circulation
Reporting caveatTrue burden is higher
Comparability caveat: many countries have reduced routine COVID-19 case reporting, so recent country totals should not be treated as a complete league table of current infection burden.

Common questions

Frequently asked questions

Reference content

Sources

  1. 1. WHO. Coronavirus disease (COVID-19) fact sheet. Source ↗
  2. 2. CDC. Symptoms of COVID-19. Source ↗
  3. 3. CDC. Testing for COVID-19. Source ↗
  4. 4. CDC. Types of COVID-19 Treatment. Source ↗
  5. 5. WHO. COVID-19 vaccines. Source ↗
  6. 6. WHO. Tracking SARS-CoV-2 variants. Source ↗

This article is based on trusted medical sources and has undergone clinician review. It is not a substitute for personalized medical advice.